By Adama Makasuba
At least 11 people have tested positive for the deadly coronavirus few days after the tedious recently concluded campaign and presidential election.
According to the Ministry of Health Covid-19 situational report “11 new cases were registered (Cumulative cases 10,045), 2, 3, 5 and 1 cases were registered on the 8th 9th 10th and 11th. The test positivity rate is 0.66% (11/1657), NPHL –1594 (11 positives) and MRCG – 63 (0 Positives) while one (1) case is currently on oxygen therapy.”
Coronavirus restrictions and measures were given little or no attention during the electoral process which saw politicians and their supporters flouting the rules at their campaigns as they sought votes from Gambian electorates
The disease has so far killed more hundred people and infected more than thousand people since it emerged in the country in 2020.
The report emphasized that “This is the 407th national situation report since the confirmation of the first case of the coronavirus disease (COVID-19) in The Gambia, on the 16th March 2020.
No new COVID-19-related death registered, bringing the total to 342 (Crude Case-Fatality Ratio, 3.4%)
“Three (3) case were discharged after at least 10 days from the day they tested positive but evaded institutional isolation and (1) from COVID-19 treatment centers. As of 9th December 2021, the following number of people have been vaccinated with: Johnson & Johnson: Only 1 dose: 197,073, Sinopharm: Dose 1: 4,468 Dose 2: 3,313, AstraZeneca: Dose 1: 40,661, Dose 2: 27,880,” the ministry added.
According to the ministry’s report, targeted population “(based on microplanning estimates – 1,564,214), proportion of target population fully vaccinated (2 doses of AZ/Sinopharm OR 1 dose of
J&J): 14.6%. Proportion of target population that received at least one Covid-19 vaccine dose (AZ OR J&J OR Sinopharm): 15.5%.
It also said that the total population based on final MoH population projections for 2021 – 2,438,899). Proportion of total population fully vaccinated (2 doses of AZ/Sinopharm OR 1 dose of J&J): 9.4%. Proportion of total population that received at least one Covid-19 vaccine dose (AZ OR J&J OR
Sinopharm): 9.9%,” it concluded.
